Physiotherapeutic management of a patient with amyotrophic lateral sclerosis
DOI:
https://doi.org/10.52428/20756208.v18i45.977Keywords:
Enfermedad Neurodegenerativa, Esclerosis Amiotrófica Lateral, Apoyo en el Sistema MusculoesqueléticoAbstract
The Amyotrophic Lateral Sclerosis disease is considered one of the most common diseases in our environment today, in turn it is one of the most tragic for patients who suffer from it, in addition to their family and social environment in general. This neurodegenerative disease does not show a clearly studied and defined etiology, despite its unknown origin, the worldwide prevalence is still too high, varying between 2 and 11 cases per 100,000 people; The approximate age of presentation is from 58 to 63 years for the less frequent cases, and from 47 to 52 years for the most frequent cases. Knowing one more proposal for physiotherapeutic treatment is of vital importance.
Downloads
References
Hardiman O, van den Berg LH, Kiernan MC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol. 2011 Oct;7(11):639-49. DOI 10.1038/nrneurol.2011.153
https://doi.org/10.1038/nrneurol.2011.153 DOI: https://doi.org/10.1038/nrneurol.2011.153
Andersen PM, Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know? Nat Rev Neurol. 2011 Oct;7(11):603-15. DOI 10.1038/nrneurol.2011.150
https://doi.org/10.1038/nrneurol.2011.150 DOI: https://doi.org/10.1038/nrneurol.2011.150
Ravits JM, La Spada AR. ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology. 2009 Sep;73(10):805-11. DOI 10.1212/WNL.0b013e3181b6bbbd.
https://doi.org/10.1212/WNL.0b013e3181b6bbbd DOI: https://doi.org/10.1212/WNL.0b013e3181b6bbbd
D'Amico E, Factor-Litvak P, Santella RM, Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med. 2013 Dec;65:509-27. DOI 10.1016/j.freeradbiomed.2013.06.029.
https://doi.org/10.1016/j.freeradbiomed.2013.06.029 DOI: https://doi.org/10.1016/j.freeradbiomed.2013.06.029
Spreux-Varoquaux O, Bensimon G, Lacomblez L, Salachas F, Pradat PF, Le Forestier N, et al. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J Neurol Sci. 2002 Jan;193(2):73-8. https://doi.org/10.1016/s0022-510x(01)00661-x
https://doi.org/10.1016/S0022-510X(01)00661-X DOI: https://doi.org/10.1016/S0022-510X(01)00661-X
Menzies FM, Ince PG, Shaw PJ. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int. 2002 May;40(6):543-51. https://doi.org/10.1016/s0197-0186(01)00125-5
https://doi.org/10.1016/S0197-0186(01)00125-5 DOI: https://doi.org/10.1016/S0197-0186(01)00125-5
Tomkins J, Usher P, Slade JY, Ince PG, Curtis A, Bushby K, et al. Novel insertion in the KSP region of the neurofilament heavy gene in amyotrophic lateral sclerosis (ALS). Neuroreport. 1998 Dec;9 (17):3967-70. https://doi.org/10.1097/00001756-199812010-00036
https://doi.org/10.1097/00001756-199812010-00036 DOI: https://doi.org/10.1097/00001756-199812010-00036
Julien JP. ALS: astrocytes move in as deadly neighbors. Nat Neurosci. 2007 May ;10(5) :535-7. https://doi.org/10.1038/nn0507-535
https://doi.org/10.1038/nn0507-535 DOI: https://doi.org/10.1038/nn0507-535
Sathasivam S, Ince PG, Shaw PJ. Apoptosis in amyotrophic lateral sclerosis: a review of the evidence. Neuropathol Appl Neurobiol. 2001 Aug;27(4):257-74. https://doi.org/10.1046/j.0305-1846.2001.00332.x
https://doi.org/10.1046/j.0305-1846.2001.00332.x DOI: https://doi.org/10.1046/j.0305-1846.2001.00332.x
Shaw PJ. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1046-57. https://doi.org/10.1136%2Fjnnp.2004.048652
https://doi.org/10.1136/jnnp.2004.048652 DOI: https://doi.org/10.1136/jnnp.2004.048652
ELA una enfermedad sin cura y progresiva. Clinica Davila. 2021. https://www.ultimasnoticiasbolivia.com/noticias-belleza-y-salud/ela-una-enfermedad-sin-cura-que-esta-en-bolivia/
Pringle CE, Hudson AJ, Munoz DG, Kiernan JA, Brown WF, Ebers GC. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain. 1992 Apr;115 ( Pt 2):495-520. https://doi.org/10.1093/brain/115.2.495
https://doi.org/10.1093/brain/115.2.495 DOI: https://doi.org/10.1093/brain/115.2.495
Ruiz Martinez A, García García JJ. Fisiopatología de la esclerosis lateral amiotrófica. Trabajo de fin de grado. Universidad Zaragoza, Departamento de farmacología y fisiología. 2016. https://pdfslide.tips/documents/fisiopatologa-de-la-esclerosis-lateral-amiotr-3-fisiopatologa-de-la-esclerosis.html?page=1
Perez Akli M, Schiava M, Melcom M. Estudio epidemiológico multicéntrico sobre esclerosis lateral amiotrófica en la Ciudad de Buenos Aires. Neurol arg. 2017 ; 9(4) :225-230. DOI : http://dx.doi.org/10.1016/j.neuarg.2017.07.004
https://doi.org/10.1016/j.neuarg.2017.07.004 DOI: https://doi.org/10.1016/j.neuarg.2017.07.004
Lascurain Vázquez O. Esclerosis lateral amiotrófica (ELA) Enfermedad, tratamiento actual y nuevas estrategias terapéuticas; trabajo de fin de grado. Universidad del País Vasco; facultad de farmacia https://addi.ehu.es/bitstream/handle/10810/54279/TFG_Lascurain.pdf
Seco Calvo J, Sistema Nervioso, Métodos, Fisioterapia Clínica, y Afecciones para Fisioterapeutas, Editorial Medica Panamericana S.A., 2023, agosto.
![](https://revistas.univalle.edu/public/journals/2/submission_977_979_coverImage_es_ES.jpg)
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Marcos Perez-Chuquimia
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.